Experience

Cooley Advises PrizePicks on Sale to Allwyn for up to $4.15 Billion

September 22, 2025

Cooley advised PrizePicks, the largest daily fantasy sports operator in North America, on its definitive agreement for Allwyn International to acquire a majority stake in PrizePicks.

Read more

Related contacts

Kevin Cooper
Partner, New York
Mike Lincoln
Vice Chair, Reston
Vicky Kandabarow
Associate, Washington, DC
Eileen Marshall
Partner, Washington, DC
Paula Fleckenstein
Associate, Reston
Sarah Buchik
Associate, New York
Dennis F. Craig II
Associate, Washington, DC
Edward Sniezek
Associate, Reston
Asal Yunusov
Associate, New York
Mariam Kamal
Associate, New York
Philip Bowman
Partner, New York
Megan Browdie
Partner, Washington, DC
Helenanne Connolly
Partner, Reston
Christopher Kimball
Partner, Washington, DC
Adam J. Longenbach
Partner, New York
Kristen Mathews
Partner, New York
Ryan Montgomery
Partner, Boston
Stella Sarma
Partner, Brussels
Matthew Schwee
Partner, Reston
Michael Tollini
Partner, Washington, DC
David Walsh
Senior Counsel, Reston
Stacey A. Bradford
Special Counsel, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jeff Goldman
Special Counsel, Palo Alto
Kimberly Nguyen
Special Counsel, Reston
Rebecca Ross
Special Counsel, Washington, DC
Mark Cornillez-Ty
Associate, Los Angeles
David Dalton
Associate, Santa Monica
Mari Dugas
Associate, Washington, DC
Athina Gaki
Associate, Brussels
Virat Gupta
Associate, Washington, DC
Bomin Kim
Associate, New York
Alexandra Leavy
Associate, New York
Pat O'Connell
Associate, New York
Shaun (Tianjie) Wang
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Infleqtion to Go Public Through Merger With Churchill Capital Corp X

September 8, 2025

Cooley advised Infleqtion, a global leader in neutral atom-based quantum technology, on its definitive business combination agreement with Churchill Capital Corp X, with the aim to accelerate Infleqtion’s mission to commercialize quantum products that provide orders of magnitude improvement in computing and precision sensing applications.

Read more

Related contacts

Mike Nelson
Partner, Colorado
Garth Angelo Osterman
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Peter Byrne
Partner, New York
Caitlin Breitenbruck
Associate, Seattle
Christine Turner
Associate, Colorado
Won Lee
Associate, Colorado
Ryan Lewis
Associate, Colorado
Orion Armon
Partner, Colorado
Ann Bevitt
Partner, London
Chris Coulter
Partner, London
Ross Eberly
Partner, Santa Monica
David Fletcher
Partner, Washington, DC
Annie Froehlich
Partner, Washington, DC
Todd Gluth
Partner, San Diego
Charles Haley
Partner, Palo Alto
Caroline Hobson
Partner, London
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Barbara Mirza
Partner, Santa Monica
Carly Mitchell
Partner, Washington, DC
Jeremy Morrison
Partner, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Ryan Bowers
Associate, Washington, DC
Anna Caro
Associate, London
Danielle Carvalho
Associate, Boston
Grady Chang
Associate, Santa Monica
Umer Chaudhry
Associate, Washington, DC
David Dalton
Associate, Santa Monica
Maddie Drabble
Associate, London
Austin Dressen
Associate, Colorado
Megan Drill
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Peter A. Haddad
Associate, San Diego
Elaine Huang
Associate, Palo Alto
Nicollette R. Kirby
Associate, Washington, DC
Andrew Mettry
Associate
Daniel Millard
Associate, London
Emily Mok
Associate, Reston
Juan Nascimbene
Associate, London
Sarah Oliai
Associate, Washington, DC
Emma Plankey
Associate, Boston
Natalie D. Vernon
Associate, Colorado
Brandan Ward
Associate, Colorado
Zi Ye
Associate, Palo Alto
Katherine Duplay
Paralegal Specialist, Colorado
Brandon Lefebvre
Quantitative Analyst, Boston
Kathryn Benvenuti
Associate, New York

Related Practices & Industries

Argo Biopharma Announces Multi-Asset License and Option Agreements With Novartis

September 3, 2025

Cooley advised Argo Biopharma, a clinical-stage biotechnology company focused on developing next-generation small interfering RNA (siRNA) therapeutics, on its additional strategic collaboration with Novartis for multiple cardiovascular assets in Argo’s pipeline.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Jennifer Raab
Partner, Palo Alto
Freddy Yip
Associate, Hong Kong
Yuhan Wu
Associate, Palo Alto
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Julia R. Brinton
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Mari Dugas
Associate, Washington, DC
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Patrick Loofbourrow
Partner, Singapore
Phil Mitchell
Partner, New York
Bin Wang
Special Counsel, Palo Alto

Related Practices & Industries

MannKind to Acquire scPharmaceuticals for up to $360 Million

August 25, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million

Read more

Related contacts

Barbara Borden
Senior Counsel, San Diego
Rowook Park
Partner, San Diego
Julia Kim
Special Counsel, New York
Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Matthew S. Scarano
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Eric Greig
Partner, Washington, DC
Asa Henin
Partner, San Diego
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Stella Sarma
Partner, Brussels
Charity Williams
Partner, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Emily Mason
Special Counsel, Santa Monica
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Athina Gaki
Associate, Brussels
Tony P. Guan
Associate, Santa Monica
Josh Himmelstern
Associate, San Diego
Michelle Hunt
Associate
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Jacob R. Lahana
Associate, Santa Monica
Eileen Leman
Associate, Los Angeles
Walter Musgrave
Associate, San Diego
Joseph Perry
Associate, Reston
Allie Pilmer
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Vittoria Rainone
Associate, San Diego
Bartholomäus Regenhardt
Associate, Brussels
Brittany K. Wightman
Associate, San Diego
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC

Related Practices & Industries

Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines

July 27, 2025

Cooley advised Hengrui Pharma, a global pharmaceutical company, on its up to $12.5 billion agreement with GSK to develop up to 12 medicines to complement GSKs extensive respiratory, immunology and inflammation (RI&I) and oncology pipeline.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Frances Stocks Allen
Partner, London
Jiqiang Lin
Associate, New York
Freddy Yip
Associate, Hong Kong
Aaron Pomeroy
Partner, Colorado
David Wilson
Partner, London
Dr. Xiaozhen (Shawn) Yu
Partner, Washington, DC
Julia R. Brinton
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Robert Eisenbach
Of Counsel, San Francisco
Navya Dasari
Associate, New York
Rick Jantz
Associate, Santa Monica
Eerik Kukebal
Associate, London
Daniel Millard
Associate, London
Patrick Sharma
Associate, Santa Monica
Zhijing Yu
Associate, Singapore

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

Virginia

Memberships and affiliations

American Bar Association - Section of Antitrust Law

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.